Using continuous glucose monitoring to improve care for type 2 diabetes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial investigates the effectiveness of periodic continuous glucose monitoring (CGM) compared to self-monitoring of blood glucose (SMBG) in adults with type 2 diabetes. Over 16 weeks, participants will either use the FreeStyle Libre CGM system or continue with traditional SMBG methods. The study aims to enhance glucose control and patient-reported outcomes through a person-centered approach, involving discussions between patients and diabetes nurses about their glucose data. The trial is conducted across multiple primary care practices in Sweden.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adults aged 18-80 years
* Type 2 diabetes with a duration of \> 6 months
* HbA1c 45-70 mmol/mol
* Have a smartphone
* Experience of self-monitoring of blood glucose prior to the study start

Exclusion Criteria:

* Prandial insulin
* Pregnancy or planning pregnancy during the study
* Breastfeeding
* Renal disease with estimated glomerular filtration rate (eGFR) \<45 mL/ min/1.73 m2
* Active malignancy or under investigation for malignancy
* Severe visual impairment
* Severe skin allergy that inhibits the use of a continuous glucose monitoring device
* Glucocorticoids (systemic)
* Planned or currently using weight reduction medications, programs, or surgery
* Cognitively or psychologically unable to participate and read instructions
* Enrolled in other clinical trials
* Eating disorders

Where it's running

• Sophiahemmet University
  Stockholm, Sweden Recruiting

Study contacts

• Principal investigator: Unn-Britt Johansson — Sophiahemmet University
• Study coordinator: Unn-Britt Johanssson, Professor
• Email: unn-britt.johansson@shh.se
• Phone: +4684062902

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Acute Blood Flow Restriction Walking in Type 2 Diabetes

  This study tests whether adding blood flow restriction to treadmill walking affects immune cells in adults with type 2 diabetes.

  Recruiting University of British Columbia · Kelowna, British Columbia · NCT07928531

• Continuous Glucose Monitoring in Type 2 Diabetes Not on Insulin

  This study tests whether using a continuous glucose monitoring system helps people with type 2 diabetes who aren’t using insulin to improve blood sugar control and quality of life.

  Recruiting Medical University of Bialystok · Bialystok · NCT07919236

• Differentiating heart disease in autoimmune vs. type 2 diabetes

  This study tests whether adult-onset autoimmune diabetes (AID/LADA) and type 2 diabetes (T2D) differ in how diabetic heart disease develops, using advanced heart imaging in people with AID, T2D, and healthy controls.

  Recruiting University of Roma La Sapienza · Rome, Roma · NCT07911007

• Lifestyle Metabotype Study B: Understanding Personalized Glucose Responses

  This study tests how lifestyle, metabolism, and brain energy use relate to each person’s blood sugar response after meals, across people with and without prediabetes or type 2 diabetes.

  Recruiting at 2 sites German Institute of Human Nutrition · Berlin and 1 other locations · NCT07888257

• Lifestyle Metabotype Study: How Daily Habits Shape Blood Sugar

  This observational study tests whether personal lifestyle and biological factors can predict how a person’s blood sugar responds after meals.

  Recruiting German Institute of Human Nutrition · Potsdam, Potsdam-Rehbrücke · NCT07868601

• Switching to Zenagamtide From Tirzepatide in Adults With Overweight or Obesity With or Without Type 2 Diabetes

  This study tests whether adults who are overweight or have obesity (with or without type 2 diabetes) can switch from tirzepatide to a new treatment called zenagamtide to find a tolerable dose.

  Recruiting at 2 sites Phase 1 Novo Nordisk A/S · Glendale, California and 1 other locations · NCT07868354

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.